Growth Opportunities in Nanocatalysts, Nanomaterials for Energy Storage and Healthcare Applications: Graphene-Based Dispersion Using Nanoplatelets – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Growth Opportunities in Nanocatalysts, Nanomaterials for Energy Storage and Healthcare Applications" report has…

2021 BRIC+M Emerging Market Risk Comparisons Report – Identify Major Near-term and Long-term Risks in Leading Emerging Markets – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "The BRIC+M Emerging Market Risk Comparisons Report" report has been added to ResearchAndMarkets.com's…

Expedera Raises $18M Series A Funding to Advance Its Deep Learning Accelerator IP

Funding will enable Expedera to meet growing customer demand for its AI Semiconductor IP SANTA…

Cloudflare Helps Businesses Manage Their Cyber Risk; Announces Partnerships with Leading Cyber Insurers and Incident Response Providers

Now organizations of any size can qualify for better cyber insurance access and rates just…

AM Best Affirms Credit Ratings of Fubon Insurance Vietnam Co., Ltd.

SINGAPORE--(BUSINESS WIRE)--#insurance--AM Best has affirmed the Financial Strength Rating of B++ (Good) and the Long-Term…

One Creation and Australian Stock Exchange (ASX) Collaborate to Deliver Privacy as a Service

NEW YORK--(BUSINESS WIRE)--#data--Following the earlier announcement of ASX’s new Distributed Ledger Technology (DLT) as a…

Kyriba Announces the Appointment of an Executive Advisory Board

Kyriba Appoints Four Executive Board Advisors to Stimulate Innovation Plans, Business Agility and Economic Growth…

Tetra Tech Wins $24 Million USAID Carbon Mitigation and Biodiversity Conservation Contract

PASADENA, Calif.--(BUSINESS WIRE)--#USAID--Tetra Tech, Inc. (NASDAQ: TTEK), a leading provider of high-end consulting and engineering…

CloudBees Raises $245 Million in New Financing

Investments aimed at product innovation, talent, and global expansion to enable enterprises to compete and…

ENHERTU® Additional Analyses Further Reinforce Groundbreaking Efficacy in Patients with HER2 Positive Metastatic Breast Cancer

DESTINY-Breast03 data presented at SABCS 2021 showed Daiichi Sankyo and AstraZeneca’s ENHERTU demonstrated a similar…